Table 2.
HLA type I alleles that are not included in the NMDP database
| HLA-A | HLA-B | HLA-C | |||
|---|---|---|---|---|---|
| Caucasian | |||||
| A*11:303 | Renal cell carcinoma ×2 | B*08:222 | Renal cell carcinoma | C*02:10 | Colon cancer |
| Prostate cancer | Pancreatic cancer | ||||
| Breast cancer | Breast cancer | ||||
| Esophageal adenocarcinoma | |||||
| Cholangiocarcinoma | |||||
| Endocervical adenocarcinoma | |||||
| SMARCA4-deficient malignant neoplasm | |||||
| A*01:215 | Renal cell carcinoma ×2 | B*44:323 | Urothelial carcinoma | C*03:32 | Breast cancer |
| Endocervical adenocarcinoma | |||||
| A*02:771 | Breast cancer | B*51:239 | Breast cancer | C*04:356 | Colon cancer |
| Esophageal squamous cell carcinoma | High-grade serous carcinoma | ||||
| A*24:01 | Endometrial adenocarcinoma | B*35:208 | High-grade serous carcinoma | C*06:227 | Renal cell carcinoma |
| Colon cancer | |||||
| A*02:724 | Breast cancer | B*44:225 | Nasopharyngeal carcinoma | C*07:18 | SMARCA4-deficient malignant neoplasm |
| A*02:802 | Glioblastoma | B*44:269 | Malignant PEComa | ||
| A*02:705 | Urothelial carcinoma | B*46:24 | Breast cancer | C*12:143 | Colon cancer |
| A*02:89 | Renal cell carcinoma | B*51:260 | Colon cancer | ||
| Hispanic or Latino | |||||
| A*11:303 | Colon cancer | ||||
| Cholangiocarcinoma | |||||
| Black or African American | |||||
| A*01:252 | Stomach cancer | B*08:222 | High-grade serous carcinoma | C*08:32 | Urothelial carcinoma |
| Asian American and Pacific Islander | |||||
| A*11:303 | Colon cancer | ||||